October 26, 2022
Ryvu Therapeutics presents new clinical and preclinical data for RVU120 program at 34th AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Symposium
Year
2022
Assets in this page
Download assets
- pdf file
Current Report ESPI 24/2022
Download